In December 2019, SARS-CoV-2 (severe acute respiratory syndrome coronavirus 2), a novel coronavirus provisionally known as 2019 novel coronavirus (2019-nCoV), has been emerged in Wuhan (Hubei province, China) causing outbreak of COVID-19 (coronavirus disease 2019) [1]. The 2019-nCoV, which is genetically different from two previously reported human-infecting β-coronaviruses: SARS-CoV (severe acute respiratory syndrome coronavirus) and MERS-CoV (Middle East respiratory syndrome coronavirus), has been considered as a new β-coronavirus and named as SARS-CoV-2 (subgenus: Sarbecovirus) [2,3].

References

1. CDC. “Coronavirus Disease 2019 (COVID-19)” (2020).
2. Lu R., et al. “Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding”. Lancet 395 (2020): 565-574.
3. Chu DKW., et al. “Molecular diagnosis of a novel coronavirus (2019-nCoV) causing an outbreak of pneumonia”. Clinical Chemistry (2020).
4. Huang C., et al. “Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China”. Lancet 395 (2020): 497-506.
5. Zhao P., et al. “A pneumonia outbreak associated with a new coronavirus of probable bat origin”. Nature (2020).
6. WHO. “2019-nCoV outbreak is an emergency of international concern” (2020).
7. WHO. “Coronavirus disease 2019 (COVID-19) Situation Report – 45” (2020). 
8. Zhao S., et al. “Preliminary estimation of the basic reproduction number of novel coronavirus (2019-nCoV) in China, from 2019 to 2020: a data-driven analysis in the early phase of the outbreak”. International Journal of Infectious Diseases 92 (2020): 214-217. 
9. Editorial. “The pandemic question”. Nature 579 (2020): 7.
10. Harrison C. “Coronavirus puts drug repurposing on the fast track”. Nature Biotechnology (2020).
11. Shang W., et al. “The outbreak of SARS-CoV-2 pneumonia calls for viral vaccines”. NPJ Vaccines 8 (2020).

Citation

Citation: Shyamapada Mandal. “COVID-19: An Ongoing Global Epidemic of Novel Coronavirus (2019-nCoV/SARS-CoV-2) Infection" Acta Scientific Microbiology 3.5 (2020): 01-02.

Copyright

Copyright: © 2020 Shyamapada Mandal. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.